Skip to main content
. 2021 Jun 30;10(2):377–396. doi: 10.1007/s40119-021-00232-8

Table 1.

In-hospital and potential late sequelae in COVID-19 patients with myocarditis

Acute phase Potential late sequelae
Clinical presentation Instrumental findings

Fever, chest pain, dyspnea, syncope

HF with normal or dilated left ventricle and reduced EF

HF with normal or dilated left ventricle and arrhythmias

Cardiogenic shock

Sudden cardiac death

Elevated troponin/BNP/CRP/IL6

ECG: ST segment abnormalities, T wave inversion, arrhythmias

Echocardiography: normal-sized or dilated left ventricle with normal or reduced EF; pericardial effusion

CMR: global or regional anomalies of T2 signal, late gadolinium enhancement

Histology: immune cell infiltrates, fibrosis, myocytolysis

Left/right ventricular dysfunction

Tachyarrhythmias

High degree of heart block

Chronic pericardial effusion

Sudden cardiac death

Recovery

EF ejection fraction, BNP brain natriuretic peptide, CMR cardiac magnetic resonance, CRP C reactive protein, ECG electrocardiogram, HF heart failure, IL6 interleukin 6